Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Nov 10, 2016 4:47pm EST

Heat Biologics Provides Corporate Update and Reports Third Quarter 2016 Financial Results

Nov 07, 2016 7:00am EST

Heat Biologics to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 25, 2016 7:00am EDT

Heat Biologics and University of Miami Announce Zika Vaccine Collaboration

Oct 17, 2016 7:30am EDT

Heat Biologics to Present at Two Upcoming Investor Conferences and Panel Discussion

Oct 13, 2016 7:00am EDT

Heat Biologics Remains on Track to Achieve Multiple Topline Data Readouts this Quarter

Oct 11, 2016 7:30am EDT

Heat Biologics Selects Adaptive Biotechnologies to Discover Potential Clinical Biomarkers to Advance Novel Immunotherapies

Oct 07, 2016 7:00am EDT

Heat Biologics Substantially Reduces Debt and Reports Proceeds of Approximately $2.8 Million Year-to-Date from the Exercise of Warrants

Sep 14, 2016 7:00am EDT

Heat Biologics Resumes Enrollment in its Non-Small Cell Lung Cancer Trial Evaluating HS-110 in Combination with Anti-PD-1 Checkpoint Inhibitor

Sep 13, 2016 7:00am EDT

Heat Biologics to Present at Two Upcoming Investor Conferences

Aug 15, 2016 4:15pm EDT

Heat Biologics Provides Corporate Update and Reports Second Quarter 2016 Financial Results

rss_feed News RSS